Inhibition of xanthine oxidase by synthetic cytokinin analogues. 1997

S Y Sheu, and Y C Lin, and H C Chiang
School of Pharmacy, Taipei Medical College, Taiwan, ROC.

Thirteen synthetic cytokinin analogues were tested for their inhibitory effects on xanthine oxidase. The enzyme, xanthine oxidase catalyses the oxidation of hypoxanthine to xanthine and of xanthine to uric acid, which has a gamma max of 295 nm, forming the basis for a spectrophotometric assay of the activity of xanthine oxidase. The results showed that 8-azaadenine(1), 4-amino-6-hydroxypyrazolo [3,4-d] pyrimidine(4), 4-amino-6-mercaptopyrazolo [3,4-d] pyrimidine(5) and 4-aminopyrazolo [3,4-d] pyrimidine(6) display inhibitory effects on xanthine oxidase with an order of activity of IC50 = 0.54, 5.91, 8.17 and 25.46 microM, respectively. Their apparent inhibition constants (Ki) were 0.66, 1.54, 6.61 and 26.79 microM, and induced mixed(competitive-non-competitive), competitive, mixed (competitive-non-competitive), and competitive types of inhibition respectively, with respect to the substrate xanthine.

UI MeSH Term Description Entries
D003583 Cytokinins Plant hormones that promote the separation of daughter cells after mitotic division of a parent cell. Frequently they are purine derivatives. Cytokinin
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014969 Xanthine Oxidase An iron-molybdenum flavoprotein containing FLAVIN-ADENINE DINUCLEOTIDE that oxidizes hypoxanthine, some other purines and pterins, and aldehydes. Deficiency of the enzyme, an autosomal recessive trait, causes xanthinuria. Hypoxanthine Oxidase,Hypoxanthine Dehydrogenase,Hypoxanthine-Xanthine Oxidase,Purine-Xanthine Oxidase,Dehydrogenase, Hypoxanthine,Hypoxanthine Xanthine Oxidase,Oxidase, Hypoxanthine,Oxidase, Hypoxanthine-Xanthine,Oxidase, Purine-Xanthine,Oxidase, Xanthine,Purine Xanthine Oxidase

Related Publications

S Y Sheu, and Y C Lin, and H C Chiang
August 1980, Biochemical pharmacology,
S Y Sheu, and Y C Lin, and H C Chiang
October 1999, Bioscience, biotechnology, and biochemistry,
S Y Sheu, and Y C Lin, and H C Chiang
October 1987, Chemical & pharmaceutical bulletin,
S Y Sheu, and Y C Lin, and H C Chiang
October 1998, Free radical research,
S Y Sheu, and Y C Lin, and H C Chiang
January 1995, Anticancer research,
S Y Sheu, and Y C Lin, and H C Chiang
March 1984, Biochemistry,
S Y Sheu, and Y C Lin, and H C Chiang
December 1950, Archives of biochemistry,
S Y Sheu, and Y C Lin, and H C Chiang
July 1982, The Journal of biological chemistry,
S Y Sheu, and Y C Lin, and H C Chiang
August 1985, Archives of biochemistry and biophysics,
S Y Sheu, and Y C Lin, and H C Chiang
April 2004, Biochimica et biophysica acta,
Copied contents to your clipboard!